Objective: To assess the effectiveness of surface neuromuscular electrical stimulation in the treatment of knee osteoarthritis. Design: Systematic review and meta-analysis of randomized controlled and controlled clinical trials Methods: Studies were identified from databases (MEDLINE, EMBASE, CINAHL, Sports Discus, PEDro and the Cochrane Library) searched to January 2011 using a battery of keywords. Two reviewers selected studies meeting inclusion criteria. The methodological quality of the included studies was assessed using the Thomas Test and the strength of the evidence was then graded using the Agency for Health Care Policy and Research guidelines. Data were pooled and meta-analyses were performed. Results: Nine randomized controlled trials and one controlled clinical trial, studying a total of 409 participants (n = 395 for randomized controlled trials, and n = 14 for controlled trial) with a diagnosis of osteoarthritis were included. Inconsistent evidence (level D) was found that neuromuscular electrical stimulation has a significant impact on measures of pain, function and quadriceps femoris muscle strength in knee osteoarthritis. Conclusion: The role of neuromuscular electrical stimulation in the treatment of knee osteoarthritis is ambiguous. Therefore, future work is needed in this field to clearly establish the role of neuromuscular electrical stimulation in this population.
Introduction
Osteoarthritis is the most common form of arthritis predominantly affecting the large weight-bearing joints of the body such as the knee. Symptoms associated with knee osteoarthritis include joint instability, pain on weight-bearing and/or at rest, reduced range of motion and disuse atrophy and weakness of the quadriceps femoris muscle. Functional disability arises from pain and loss of quadriceps femoris strength, both of which reduce quality of life and increase the risk of further morbidity and mortality. 1 Exercise therapy aims to decrease pain and increase quadriceps femoris strength, therefore improving functional capacity for those with knee osteoarthritis. The American College of Rheumatology has approved regular exercise as a therapeutic approach 2 with both aerobic and strengthening exercises shown to improve pain and physical function in patients with knee osteoarthritis. 3 Neuromuscular electrical stimulation consists of electrically stimulating muscle and/or nerves to induce a muscle contraction. It increases the load on the muscle using an electrically induced contraction and can therefore be used to improve muscle strength. 4 Evidence suggests that neuromuscular electrical stimulation can increase strength of the quadriceps femoris muscle and decreases pain in knee osteoarthritis, 5, 6 however this has not been thoroughly investigated. A previous systematic review published in 2000 identified strong evidence for the beneficial application of neuromuscular electrical stimulation in knee osteoarthritis, however the authors highlighted limitations which included the limited number of included studies, their small sample sizes and flawed allocation procedures. 7 In addition, patients post total knee arthroplasty were included as was the use of transcutaneous electrical nerve stimulation for pain relief.
Because of the expansion of research in the area of neuromuscular electrical stimulation in the past decade, an update on the current evidence is required. Hence this study was undertaken to systematically review the literature to determine the efficacy of surface neuromuscular electrical stimulation as a method of improving quadriceps femoris muscle strength, pain and function in patients with knee osteoarthritis.
Methodology
The review comprised three phases. In phase 1 an extensive literature search of the following databases was conducted up to January 2011: MEDLINE, EMBASE, CINAHL, Sports Discus, PEDro and the Cochrane Library. The search terms relating to osteoarthritis and neuromuscular electrical stimulation used in the MEDLINE search were modified for the other databases (Appendix 1). Citation lists from all included studies were also searched.
Inclusion criteria included randomized controlled trials and controlled clinical trials, published in English, or translated into English between 1986 and 2011, and conducted on human adults with a diagnosis of unilateral or bilateral knee joint osteoarthritis. Studies that used neuromuscular electrical stimulation in combination with any other therapeutic intervention or exercise programme, as well as those comparing neuromuscular electrical stimulation to exercise interventions/non-exercise interventions or combinations of exercise with different conservative treatments were included. Exclusion criteria included participants who had undergone total knee replacement or uni-compartmental replacement or had any history of inflammatory disease such as rheumatoid arthritis. Studies that investigated the use of transcutaneous electrical nerve stimulation or pulsed electromagnetic stimulation were also excluded, along with studies that used implantable electrodes.
In phase 2, two reviewers (OMG and GFC) assessed studies generated from the search strategy for inclusion using the title and/or the abstract if there was ambiguity in the study title. Full copies of potentially relevant studies were then obtained for detailed examination. The two reviewers then reviewed the full text of the potential studies to determine their suitability. Where disagreement existed between the reviewers on the inclusion of a study, a third independent reviewer (BMF) was assigned to review the manuscript. A detailed proforma was developed to capture and categorize the results of the included studies into three main themes: the effects of neuromuscular electrical stimulation on pain, on function and on quadriceps femoris muscle strength.
In phase 3, the quality of the studies was assessed using the Thomas Test 9 which has been identified in the literature 8 as the most appropriate tool for quality assessment for studies involving both randomized and non-randomized controlled trials. Two reviewers (OMG and GFC) independently graded the quality of the included studies according to the following components: selection bias, study design, confounders, blinding, data collection methods, withdrawals and drop-outs. These component ratings then gave a global rating of strong, moderate or weak. The strength of the evidence was then graded according to the grading system used in the Agency for Health Care Policy and Research (AHCRP) guidelines. 8 Minor amendments were made to the grading system 9 to include level B category for trials of moderate quality. Where appropriate, study results were pooled and meta-analyses were undertaken. Considering the clinical heterogeneity of the included studies the meta-analyses were limited to studies where outcome measures included the Western Ontario and McMaster Osteoarthritis Index (WOMAC) pain and function scores, and walking tests. The analysis was undertaken using Review Manager Software package RevMan 5 (version 5.0.25, updated 2010 Cochrane Collaboration). For the continuous data where different scales were employed by different studies for the assessment of the same outcome (e.g. walking test) the standardized mean difference (SMD) with 95% confidence intervals (CI) were calculated using a random effect model. Where the same scale was employed (e.g. for pain and function (WOMAC)), the mean differences with 95% CI were used. Authors were contacted in cases of incomplete data.
Results
Nine randomized controlled trials and one controlled clinical trial were included in the review. Figure 1 summarizes the results of all database searches. There was full agreement between the reviewers on the inclusion of all of the studies. A summary of the study characteristics is shown in Table 1 .
Participants studied
In total, 409 patients (female n = 312, male n = 83, not reported n = 14) with knee osteoarthritis were included in the ten studies (n = 395 for randomized controlled trials and n = 14 for controlled clinical trials), where patient numbers in each intervention study ranged from 7 to 57. All participants had either radiographic evidence (>grade 1 on the Kellgren and Lawrence Scale) of knee osteoarthritis, or where radiographic evidence was not reported, clinical evidence of knee osteoarthritis. 10, 11 Participants were recruited from a range of clinical settings: an osteoarthritis database, an outpatient department in the study centre, from a total knee arthroplasty waiting list or by self-selection (advertisements). Four studies did not detail the method of participant recruitment. 1, 6, 12, 13 All but one study 10 identified the proportion of male and female participants, with a greater proportion of females participating in every study. The participants' age ranged from 52 to 71 years. Mean body mass index ranged from 29.3-32.9 kg/m 2 . Three studies did not detail the body mass index of the participants studied. 1, 10, 11 
Treatment approaches
The neuromuscular electrical stimulation treatment protocols employed in each study are summarised in Table 1 . All but one study reported the parameters used. 14 The neuromuscular electrical stimulation pulse frequency used ranged from 25 to 50 Hz, with 50 Hz the most common frequency emplo yed. 1, 5, 12, [15] [16] [17] Choice of machine, treatment times and electrode placement varied between the studies.
Outcome measures
Both self-report and objective outcome measures were included ( and ten-repetition maximum (10RM), maximum voluntary contraction and force of the quadriceps femoris) and functional assessments/physical activity measurements (timed walk, timed stair climb, timed sit-to-stand, balance, accelerometry). Other objective measurements included knee range of motion, knee and thigh circumference, quadriceps femoris cross-sectional area and protein synthesis and histological markers.
Study quality
The Thomas Test rated the quality of two studies as strong, 5, 15 four studies as moderate 1, [11] [12] [13] and four studies as weak. 6, 10, 14, 17 The component ratings and global ratings are summarized in Table 2 .
Impact of neuromuscular electrical stimulation on pain
Eight studies investigated the impact of neuromuscular electrical stimulation on pain. 1, 5, 6, [12] [13] [14] [15] 17 A range of self-report outcome measures were used: visual analogue scale, 1,12-15 WOMAC pain subscale, 1, [12] [13] [14] [15] 17 the Pain Rating Index Total, 6 a pain diary, 6 the pain subscale of the Arthritis Impact Measurement Scale 2, 6 the Present Pain Intensity scale 6 and the McGill Pain Questionnaire. 5, 6 Inconsistent evidence (level D) from eight papers found that neuromuscular electrical stimulation alone, or in combination with other therapeutic interventions, had a significant impact on selfreported pain in osteoarthritis.
Four studies of moderate or strong methodological quality, 1, 12, 13, 15 reported that neuromuscular electrical stimulation alone or combined with other therapeutic interventions, such as infrared, interferential ultrasound and continuous passive movement, 1 interferential therapy 15 and exercise, 13 can significantly improve pain in knee osteoarthritis. One study of weak methodological quality reported that neuromuscular electrical stimulation alone was as effective as conventional exercise in improving knee pain in osteoarthritis. 14 severity of pain following a neuromuscular electrical stimulation intervention. 5, 16, 17 
Impact of neuromuscular electrical stimulation on function
Eight studies investigated the impact of neuromuscular electrical stimulation on patient function. 1, 5, [11] [12] [13] [14] [15] 17 A range of self-report and objective outcome measures were used: WOMAC function subscale, 1, [12] [13] [14] [15] 17 timed walk, 5, 12, 13, 17 timed stairs climb, 5, 11, 12, 14 timed sit-to-stand, 5,11 balance measure 1 and the Functional Performance Inventory. 5 Inconsistent evidence (level D) was found in the eight papers that neuromuscular electrical stimulation significantly improved patient function. Four investigations demonstrated that neuromuscular electrical stimulation alone, or when combined with other therapeutic interventions (infrared, interferential therapy, ultrasound and continuous passive movement 1 ) or exercise 13 is as effective as conventional exercise in improving measures of function in knee osteoarthritis. 1, [12] [13] [14] Similarly, two investigations found that neuromuscular electrical stimulation is capable of significantly improving levels of function greater than a control intervention. 5, 15 However, two studies reported no significant difference between intervention and control group; in a timed walk and timed sit-tostand following interventions with different stimulation patterns, 11 or in terms of self-reported function following a four-week neuromuscular electrical stimulation intervention. 17
Impact of neuromuscular electrical stimulation on strength
Eight studies investigated the impact of neuromuscular electrical stimulation on quadriceps femoris muscle strength. 1, 5, [10] [11] [12] [13] [14] 17 Objective measures of strength included one and ten repetition maximum, 12 manual muscle testing 14 and quadriceps femoris torque measurements. 1, 5, 10, 11, 13, 17 There is inconsistent evidence (level D) from the eight papers that neuromuscular electrical stimulation alone, or in combination with other therapeutic interventions, had a significant positive impact on measures of quadriceps femoris muscle strength in knee osteoarthritis. Significant improvements in quadriceps femoris strength measures were noted following a neuromuscular electrical stimulation intervention in three studies. 5, 12, 14 One paper 1 reported that combined continuous passive movement and neuromuscular electrical nerve stimulation is effective in increasing strength in this population. However, three studies demonstrated no significant improvements in strength following a neuromuscular electrical stimulation intervention. 10, 13, 17 It has been suggested that there may be a significant placebo effect associated with neuromuscular electrical stimulation, as strength gains were observed in this study following sham stimulation. 11
Meta-analyses results
Pooled data from six studies examining pain and function outcome measures were included in the meta-analyses. 1, 5, 12, 13, 15, 17 One study was excluded as original data could not be obtained from the authors. 14 A meta-analysis was undertaken to determine the impact of neuromuscular electrical stimulation on the WOMAC function scores. From a total of 233 patients, the point estimate for differences between the experimental and control groups at follow-up was -5.31 (-10.32 to -0.40) in favour of the experimental group (Table 3) .
A pooled analysis was also undertaken for the WOMAC pain scores. From a total of 225 patients, the point estimate for differences between the experimental and control groups at follow-up was -1.32 (-2.40 to -0.23) in favour of the experimental group (Table 4 ). 
Favours experimental Favours control
A meta-analysis was also undertaken to determine the impact of neuromuscular electrical stimulation on a walking test. From a total of 134 patients, the point estimate for differences between the experimental and control groups at follow-up was 0.23 (-0.33 to 0.80), indicating no significant difference between the experimental and control groups ( Table 5 ).
Discussion
Ten studies investigating the impact of neuromuscular stimulation in the treatment of knee osteoarthritis fulfilled the inclusion criteria for the review. The quality of the studies was strong (n = 2), moderate (n = 4) or weak (n = 4). Overall there is inconsistent evidence (level D) that neuromuscular electrical stimulation significantly reduced pain and increased strength and function in patients with knee osteoarthritis. However, the results of the pooled analyses from six studies found that neuromuscular electrical stimulation improved levels of self-reported pain and function, but not objective measures of function in this population. Nonetheless, these results should be interpreted with caution due to the heterogeneity of studies and the low number of studies included as demonstrated by the I 2 statistic.
The results of the present review should be considered with respect for the following limitations. Both randomized controlled trials and a controlled clinical trial were included in this review. While there is less agreement on critical appraisal tools for the evaluation of non-randomized studies, a valid and reliable tool previously used in systematic reviews (Thomas Test) rated the quality of the studies. In addition only studies published in English or translated into English were included, meaning that some studies may have been overlooked. The limited number of studies included in the meta-analyses due to study heterogeneity may also limit findings.
The development of treatment protocols for the management of symptoms (pain, reduced strength and function) in patients with knee osteoarthritis is important. It is estimated that 10% of people older than 55 years have symptoms of osteoarthritis, a quarter of whom are severely disabled. 18 As a disease, osteoarthritis is now also being identified in adults at younger ages, 19 thus if effective interventions are not developed, joint replacement surgery will be needed at earlier ages to maintain mobility and quality of life.
In the elderly population with knee osteoarthritis reduced quadriceps strength and increased postural sway have been reported, both of which may be related to falls. 20, 21 Falls in the older population has been recognized as a significant health issue in today's society. 22 It is estimated that one in every three people over the age of 65 and one in two people over the age of 80 years fall every year 23 with fall-related injuries the leading cause of injury and disability among adults greater than 65 years. 24 Given the expected rise in the age of the population in Europe, 25 developing protocols to maximize strength and proprioception in the lower extremity is important.
A previous systematic review has provided strong evidence demonstrating that conventional exercise has significant benefits in terms of knee pain and physical function in knee osteoarthritis. 26 Neuromuscular electrical stimulation has been suggested as a method for increasing strength of the quadriceps femoris and decreasing pain in knee osteoarthritis, but findings to date have been inconclusive. The findings of the current review concur with the findings reported by Monaghan et al. 4 who found that there was inconclusive evidence regarding the effectiveness of surface neuromuscular electrical stimulation as a means of improving quadriceps femoris strength in knee osteoarthritis patients both before and after total knee replacement. This review was very small with only two studies included, both with a high risk of methodological bias. Hulme et al. 27 also reported inconclusive findings in their review regarding the effects of pulsed electromagnetic stimulation in the treatment of osteoarthritis. Conversely, Marks and colleagues 7 suggested that there was strong evidence to support the application of neuromuscular electrical stimulation to strengthen the quadriceps femoris muscle; however, confidence in these conclusions is weakened by the limitations presented earlier.
The challenge of developing protocols for this patient cohort is that in the published literature there is no consistency in the neuromuscular electrical stimulation parameters used. In the current review six studies employed neuromuscular electrical stimulation at a frequency of 50 Hz 1, 5, 6, 12, 15, 17 to produce smooth tetanic muscle contractions, 10,28 a condition which is favourable for strengthening the quadriceps femoris muscle. 29 However, a range of other frequencies were also included (25 Hz, 13 30 Hz 10 and pulse patterns at a frequency of 8.4 Hz 11 ). In addition, parameters of pulse width versus duration and intensity showed great variability between studies: one paper 5 applied stimulation at an intensity which produced quadricep femoris contractions at 10-40% of maximum voluntary contraction, while a second 17 reported using stimulation intensities which produced at least 35% of maximum voluntary contraction. Further research is necessary to clearly establish the optimal neuromuscular electrical stimulation parameters for use in this population. In addition, standardizing cointerventions is warranted in the development of protocols for use in the clinical setting to maximize the impact of this intervention. In the current review the lack of consistency between studies makes this difficult: six studies [10] [11] [12] [13] [14] 17 investigated the application of neuromuscular electrical stimulation alone, while a further four studies combined neuromuscular electrical stimulation with other therapeutic interventions. 1, 5, 6, 15 The conflicting data from the studies identified in the current review does not allow any definitive conclusion to be made with regard to the use of neuromuscular electrical stimulation to reduce pain and to increase quadriceps femoris strength and function in knee osteoarthritis. Nevertheless, the existing evidence is promising, with a greater number of moderate-strong quality randomized controlled trials suggesting the use of neuromuscular electrical stimulation in this population. In particular, neuromuscular electrical stimulation may prove to be a useful therapeutic alternative for individuals with knee osteoarthritis who are unable to carry out conventional exercise due to the presence of coexisting disease. Future studies in this field should be conducted to establish protocols using neuromuscular electrical stimulation to increase patient function, reduce pain and maximize quality of life.
Clinical messages
• There is inconsistent evidence regarding the impact of neuromuscular electrical stimulation on measures of pain, function and quadriceps femoris muscle strength in knee osteoarthritis. • Future work is needed in this field to clearly establish the role of neuromuscular electrical stimulation in knee osteoarthritis and to determine the optimal neuromuscular electrical stimulation protocol to use in this population.
